Pharmaceutical

GW Pharmaceuticals

$144.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.53 (+1.07%) As of 3:57 PM UTC today

Why Robinhood?

You can buy or sell GWPH and other stocks, options, and ETFs commission-free!

About GWPH

GW Pharmaceuticals Plc American Depositary Shares, also called GW Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. The listed name for GWPH is GW Pharmaceuticals Plc American Depositary Shares.

CEO
Justin D. Gover
Employees
901
Headquarters
Cambridge, Cambridgeshire
Founded
2001
Market Cap
4.37B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
449.87K
High Today
$145.37
Low Today
$141.54
Open Price
$141.93
Volume
57.39K
52 Week High
$145.37
52 Week Low
$67.98

Collections

GWPH Earnings

-$0.87
-$0.58
-$0.29
-$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 24, After Hours
Replay Earnings Call

You May Also Like

LFC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure